日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms

骨髓增生异常综合征中转座元件和PIWI相互作用RNA的失调

期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-025-00725-x
Krejcik, Zdenek; Kundrat, David; Klema, Jiri; Hrustincova, Andrea; Trsova, Iva; Belickova, Monika; Cermak, Jaroslav; Jonasova, Anna; Dostal, Jiri; Dostalova Merkerova, Michaela
PIWI
发表日期：2025
文献求助 收藏

Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes

非编码 RNA 及其对接受阿扎胞苷治疗的骨髓增生异常综合征患者和伴有骨髓增生异常相关改变的急性髓系白血病患者的反应预测价值

期刊:Cancer Genomics & Proteomics
影响因子:2.6
doi:10.21873/cgp.20315
Michaela Dostalova Merkerova, Jiri Klema, David Kundrat, Katarina Szikszai, Zdenek Krejcik, Andrea Hrustincova, Iva Trsova, Anh Vu LE, Jaroslav Cermak, Anna Jonasova, Monika Belickova
肿瘤
白血病
发表日期：2022
文献求助 收藏

Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients

地拉罗司对骨髓增生异常综合征患者免疫反应的调节作用

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph14010041
Votavova, Hana; Urbanova, Zuzana; Kundrat, David; Dostalova Merkerova, Michaela; Vostry, Martin; Hruba, Monika; Cermak, Jaroslav; Belickova, Monika
免疫/内分泌
发表日期：2021
文献求助 收藏

LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome

lncRNA谱分析揭示H19、WT1-AS、TCL6和LEF1-AS1的失调与高危骨髓增生异常综合征相关

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers12102726
Szikszai, Katarina; Krejcik, Zdenek; Klema, Jiri; Loudova, Nikoleta; Hrustincova, Andrea; Belickova, Monika; Hruba, Monika; Vesela, Jitka; Stranecky, Viktor; Kundrat, David; Pecherkova, Pavla; Cermak, Jaroslav; Jonasova, Anna; Dostalova Merkerova, Michaela
WT1
LEF1
lncRNA
发表日期：2020
文献求助 收藏

Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

阿扎胞苷治疗的骨髓增生异常综合征和伴有骨髓增生异常相关改变的急性髓系白血病患者中miRNA表达改变与DLK1-DIO3区域DNA甲基化的关系

期刊:Cells
影响因子:5.2
doi:10.3390/cells7090138
Merkerova, Michaela Dostalova; Remesova, Hana; Krejcik, Zdenek; Loudova, Nikoleta; Hrustincova, Andrea; Szikszai, Katarina; Cermak, Jaroslav; Jonasova, Anna; Belickova, Monika
白血病
DNA甲基化
表观遗传
DNA甲基化
miRNA
DLK1
发表日期：2018
文献求助 收藏

MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia

微小RNA谱作为骨髓增生异常综合征和急性髓系白血病中阿扎胞苷治疗反应的预测标志物

期刊:Cancer Biomarkers
影响因子:1.9
doi:10.3233/CBM-171029
Krejcik, Zdenek; Belickova, Monika; Hrustincova, Andrea; Votavova, Hana; Jonasova, Anna; Cermak, Jaroslav; Dyr, Jan E; Merkerova, Michaela Dostalova
白血病
发表日期：2018
文献求助 收藏

DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population

在捷克人群中，DNA修复基因变异与骨髓增生异常综合征风险增加相关。

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/1756-8722-6-9
Belickova, Monika; Merkerova, Michaela Dostalova; Stara, Eliska; Vesela, Jitka; Sponerova, Dana; Mikulenkova, Dana; Brdicka, Radim; Neuwirtova, Radana; Jonasova, Anna; Cermak, Jaroslav
发表日期：2013
文献求助 收藏

Differential expression of microRNAs in CD34+ cells of 5q- syndrome

5q-综合征CD34+细胞中microRNA的差异表达

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/1756-8722-4-1
Votavova, Hana; Grmanova, Martina; Dostalova Merkerova, Michaela; Belickova, Monika; Vasikova, Alzbeta; Neuwirtova, Radana; Cermak, Jaroslav
细胞生物学
CD34
CD3
发表日期：2011
文献求助 收藏

Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome

骨髓增生异常综合征患者CD34+骨髓细胞中独特的microRNA表达谱

期刊:European Journal of Human Genetics
影响因子:4.6
doi:10.1038/ejhg.2010.209
Dostalova Merkerova, Michaela; Krejcik, Zdenek; Votavova, Hana; Belickova, Monika; Vasikova, Alzbeta; Cermak, Jaroslav
细胞生物学
CD34
CD3
发表日期：2011
文献求助 收藏